DDReg Pharma Pvt Ltd

DDReg Pharma Pvt Ltd Incepted in the year 2009, the company is involved in a wide variety of regulatory & drug safety assignments which span across global markets.

DDReg is a global life sciences consulting firm specializing in regulatory affairs, pharmacovigilance, and quality services, accelerating product registrations and ensuring compliance through smart RegTech and deep industry expertise. Rich subject matter expertise gets combined with cutting edge technology solutions providing end to end support across pharma value chain. The company supports globa

l pharmaceutical organizations for their needs to address regulatory challenges pertaining to Biologicals, Complex formulations, INDs, NDAs and Generics, Consumer Healthcare products and Medical Devices, in highly regulated markets as well as in complex emerging markets. The services portfolio includes Document management, Dossier support, pre-Approval and Post MA regulatory support, Submission management, Regulatory Intelligence, Regulatory Strategies, Feasibility Studies, Dossier compilation, submissions, Agency follow ups and approvals. The Drug Safety Vertical supports global organizations to manage their worldwide Safety Obligations by way of Case Management, Aggregate Reporting, Safety Compliances, Signal Detection and Risk Management. Functional and Operational Excellence are manifested through Strong Quality Management System, and Efficient Project Management.

30/04/2026

๐€๐ฉ๐ซ๐ข๐ฅ was about one thing: ๐ค๐ง๐จ๐ฐ๐ข๐ง๐  ๐ฐ๐ก๐ข๐œ๐ก ๐ฆ๐š๐ซ๐ค๐ž๐ญ๐ฌ ๐š๐ซ๐ž ๐ซ๐ž๐š๐๐ฒ ๐Ÿ๐จ๐ซ ๐ฒ๐จ๐ฎ ๐›๐ž๐Ÿ๐จ๐ซ๐ž ๐ฒ๐จ๐ฎ ๐ž๐ง๐ญ๐ž๐ซ ๐ญ๐ก๐ž๐ฆ.
From ๐’๐š๐ฎ๐๐ข ๐€๐ซ๐š๐›๐ข๐š'๐ฌ ๐’๐…๐ƒ๐€ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ซ๐ž๐ ๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง roadmap and the complexity of the region's largest drug market, to ๐„๐Œ๐€'๐ฌ ๐€๐“๐Œ๐ ๐ซ๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ฉ๐š๐ญ๐ก๐ฐ๐š๐ฒ for cell and gene therapy manufacturers navigating the EU, this month mapped the frameworks shaping global market access.
We also decoded ๐๐๐Ž๐Œ ๐๐ซ๐ฎ๐  ๐ซ๐ž๐ ๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง in Southeast Asia's largest pharma market, unpacked ๐‚๐Ž๐…๐„๐๐‘๐ˆ๐’ ๐œ๐จ๐ฌ๐ฆ๐ž๐ญ๐ข๐œ ๐š๐ฉ๐ฉ๐ซ๐จ๐ฏ๐š๐ฅ in Mexico, examined why ๐๐จ๐ฌ๐ฌ๐ข๐ž๐ซ ๐š๐ฎ๐ญ๐จ๐ฆ๐š๐ญ๐ข๐จ๐ง is rewriting drug approval timelines in 2026, and explored ๐ฏ๐ž๐ญ๐ž๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ ๐ซ๐ž๐ ๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง under ๐’๐€๐‡๐๐‘๐€'๐ฌ ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐Ÿ๐ซ๐š๐ฆ๐ž๐ฐ๐จ๐ซ๐ค in South Africa.

Explore ๐€๐ฉ๐ซ๐ข๐ฅ'๐ฌ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ on our website: https://tinyurl.com/njwjyjzz.

29/04/2026

Most registration lapses aren't caused by careless teams. They're caused by systems that were never built to scale.
Spreadsheets. Calendar reminders. Institutional memory that walks out the door. Across markets, time zones, and a portfolio that never stops growing.
When a registration lapses, the renewal fee is the smallest cost.

Market withdrawal. Revenue gap. A rework timeline nobody planned for. None of it is budgeted. All of it is avoidable.

VITALIC LC automates alerts at 180, 90, 60, and 30 days, across every jurisdiction your portfolio covers. No manual intervention required.

๐Ÿ“… Book your Demo โ†’ https://www.ddregpharma.com/products/vitalic-lc

Indiaโ€™s clinical trial approvals are becoming more structured and less forgiving of poor preparation.The 2026 CDSCO upda...
28/04/2026

Indiaโ€™s clinical trial approvals are becoming more structured and less forgiving of poor preparation.

The 2026 CDSCO updates introduce clearer pathways, stronger oversight, and fully digital processes, pushing companies toward a more disciplined, risk-based approach.

From โ€œprior intimationโ€ provisions to stricter compliance checks, success now depends on how early and how well you plan your regulatory strategy.

Delays arenโ€™t just about timelines anymore; theyโ€™re often a result of gaps in documentation, classification, or readiness.

If youโ€™re entering the Indian clinical trial space, understanding these shifts is critical.

๐Ÿ” Read here: https://tinyurl.com/4xrdktjc

27/04/2026

Submission prep runs long because the right information isn't there when prep starts.

Current authority requirements. Live dossier gaps. Recent format changes. All of it is hunted down manually before a single document gets written.
That hunting phase is where weeks disappear.

"VITALIC RegIntel" puts pre-submission requirements, dossier gap analysis, and real-time authority tracking into a single dashboard, so your team starts with complete intelligence, not a search task.

Book a demo- https://tinyurl.com/46wrf8f5

Every pharma professional knows which ICH series they work in. Far fewer can explain how all four connect, and that gap ...
26/04/2026

Every pharma professional knows which ICH series they work in.

Far fewer can explain how all four connect, and that gap shows up in submissions.

When you understand the framework, not just the guidelines, you read regulatory documents differently. You write them differently. You catch what others miss.

๐Ÿ“Œ Save it. Share it with your team: https://tinyurl.com/pnp66p4y

25/04/2026

Most compliance failures don't begin with a bad decision.

They begin with an inbox no one could keep up with.

Regulatory professionals today are navigating more authority updates, tighter deadlines, and higher-stakes decisions than ever, often with tools built for a different era.

That's not a people problem. It's a systems problem.

DDReg gives RA teams the clarity, structure, and early warnings they need to stay ahead, not just catch up.

See how: https://tinyurl.com/pnp66p4y

The GLP-1 supplement category is expanding rapidly alongside regulatory scrutiny.Claims like โ€œsupports GLP-1 naturallyโ€,...
24/04/2026

The GLP-1 supplement category is expanding rapidly alongside regulatory scrutiny.
Claims like โ€œsupports GLP-1 naturallyโ€, โ€œenhances semaglutide resultsโ€, or โ€œperfect companion to weight-loss injectionsโ€ are already under FDA and FSSAI review.

High-visibility categories face stricter enforcement. Ambiguous claims are not a grey area; they are a compliance risk.

DDRegโ€™s breakdown clarifies what regulators allow, where red lines exist, and how to frame defensible claims.

Read the full guide: https://tinyurl.com/2edrssjp

23/04/2026

Juggling registrations across markets?
Renewals slipping through the cracks?
Variations piling up?

There's a better way.

VITALIC LC brings every registration, renewal, and variation under one roof, so your team stays ahead, and nothing gets missed.

See it in action: https://tinyurl.com/27fuxb9j

Earth gives us life. We return the responsibility. This Earth Day, weโ€™re reminded that progress and sustainability must ...
22/04/2026

Earth gives us life. We return the responsibility.

This Earth Day, weโ€™re reminded that progress and sustainability must go hand in hand. From reducing paper-heavy processes to enabling digital regulatory solutions, every small shift matters.

Because protecting health isnโ€™t just about people, itโ€™s about the planet we all depend on.

Letโ€™s build a future thatโ€™s compliant, conscious, and sustainable. ๐ŸŒฑ

Visit: https://tinyurl.com/pnp66p4y

Drug development takes a decade on average. Most of that time isn't spent on science.It's spent on manual processes that...
21/04/2026

Drug development takes a decade on average. Most of that time isn't spent on science.

It's spent on manual processes that technology has already made obsolete.

AI-powered regulatory intelligence tools, from global horizon scanning to predictive approval models, are reshaping how pharma teams manage submissions, track authority updates, and respond to queries.

The question isn't whether to adopt them. It's whether your team is positioned when it matters.

๐Ÿ‘‰Full breakdown of the tools redefining the regulatory workflow: https://tinyurl.com/428kykkp

20/04/2026

Your regulatory calendar has a gap right now.

You just don't know which market it's in.

Authority updates don't pause for your team's bandwidth. Guidance changes, filing windows shift, dossier requirements get amended, and most RA teams find out after it matters.

Vitalic RegIntel monitors regulatory authorities in real time across your key markets. Flags gaps in your dossier. Alerts you before a missed update becomes a missed filing.

So, your next submission isn't a guess.

Request a demo: https://tinyurl.com/56apf6zr


Most teams donโ€™t fail compliance.They fail timing.The difference between reactive chaos and proactive control?Regulatory...
16/04/2026

Most teams donโ€™t fail compliance.

They fail timing.
The difference between reactive chaos and proactive control?

Regulatory intelligence that actually works.

DDReg bridges the gap, turning missed updates into early signals and scrambling teams into strategic leaders.

Closing the gap since 2009.

Discover how DDReg works โ†’ https://tinyurl.com/yyr78cwm

Address

Units 444-451, Tower B2, 4-floor Spaze-I-Tech Park, Sector 49, Sohna Road
Gurugram
122018

Alerts

Be the first to know and let us send you an email when DDReg Pharma Pvt Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to DDReg Pharma Pvt Ltd:

Share